These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6530661)

  • 1. [Disposition of azosemide. I. Distribution, metabolism and excretion following intravenous administration to rats].
    Asano T; Inoue T; Kurono M
    Yakugaku Zasshi; 1984 Nov; 104(11):1181-90. PubMed ID: 6530661
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of azosemide after intravenous and oral administration to rats with alloxan-induced diabetes mellitus.
    Park KJ; Yoon WH; Shin WG; Lee MG
    J Pharm Pharmacol; 1996 Oct; 48(10):1093-7. PubMed ID: 8953515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability, tissue metabolism, tissue distribution and blood partition of azosemide.
    Lee SH; Lee MG
    Biopharm Drug Dispos; 1995 Oct; 16(7):547-61. PubMed ID: 8785379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a hepatoprotective agent, YH-439, on the pharmacokinetics of furosemide and azosemide in rats.
    Kim SH; Park KJ; Yoon WH; Lee JW; Kim ND; Lee MG
    Res Commun Mol Pathol Pharmacol; 1996 Feb; 91(2):233-44. PubMed ID: 8832915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cysteine on the pharmacokinetics and pharmacodynamics of intravenous and oral azosemide in rats with protein-calorie malnutrition.
    Kim YG; Cho MK; Kwon JW; Kim SG; Kim SH; Lee MG
    Life Sci; 2001 Apr; 68(21):2329-45. PubMed ID: 11350005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver and gastrointestinal first-pass effects of azosemide in rats.
    Kim J; Kim SH; Lee MG
    J Pharm Pharmacol; 1997 Sep; 49(9):878-83. PubMed ID: 9306255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of 4-week and 8-week exercise training on the pharmacokinetics and pharmacodynamics of intravenous and oral azosemide in rats.
    Kim HJ; Lee AK; Kim YG; Bu SC; Kim SH; Yang CH; Suh OK; Kim SG; Lee MG
    Life Sci; 2002 Mar; 70(19):2299-319. PubMed ID: 12005188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azosemide kinetics and dynamics.
    Brater DC; Day B; Anderson S; Seiwell R
    Clin Pharmacol Ther; 1983 Oct; 34(4):454-8. PubMed ID: 6617067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender differences in pharmacokinetics and pharmacodynamics of azosemide in rats.
    Lee YS; Han KS; Lee MG
    Biopharm Drug Dispos; 1999 May; 20(4):225-9. PubMed ID: 10440798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circadian changes in the pharmacokinetics and pharmacodynamics of azosemide in rats.
    Han KS; Lee MG
    J Pharm Pharmacol; 1998 Jul; 50(7):767-74. PubMed ID: 9720626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of intravenous infusion time on the pharmacokinetics and pharmacodynamics of the same total dose of azosemide in rabbits.
    Park KJ; Yoon WH; Shin WG; Lee MG
    Biopharm Drug Dispos; 1997 Jan; 18(1):41-52. PubMed ID: 9008268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing the protein binding of azosemide using an equilibrium dialysis technique.
    Lee SH; Lee MG
    Biopharm Drug Dispos; 1995 Oct; 16(7):615-26. PubMed ID: 8785384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of diuretic effects and changes in plasma aldosterone concentration following oral administration of a single dose of furosemide or azosemide in healthy dogs.
    Hori Y; Katou A; Tsubaki M; Kanai K; Nakao R; Hoshi F; Itoh N; Higuchi S
    Am J Vet Res; 2008 Dec; 69(12):1664-9. PubMed ID: 19046016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects in normal subjects of long-term administration of azosemide.
    Brater C; Anderson S; Muckleroy C
    Clin Pharmacol Ther; 1979 Oct; 26(4):437-41. PubMed ID: 487690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of water deprivation for 48 hours on the pharmacokinetics and pharmacodynamics of azosemide in rats.
    Ha HA; Lee SH; Kim SH; Kim ON; Lee MG
    Res Commun Mol Pathol Pharmacol; 1996 Jul; 93(1):109-28. PubMed ID: 8865375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and pharmacodynamics of intravenous azosemide in mutant Nagase analbuminemic rats.
    Kim EJ; Lee AK; Kim SH; Kim SG; Lee MG
    Drug Metab Dispos; 2003 Feb; 31(2):194-201. PubMed ID: 12527700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The metabolism or (35S)homosulphanilamide.
    Wong LC; Millburn P; Williams RT
    Biochem J; 1971 Sep; 124(2):17P. PubMed ID: 5158478
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of neurohumoral effects of short-acting and long-acting loop diuretics in patients with chronic congestive heart failure.
    Tsutsui T; Tsutamoto T; Maeda K; Kinoshita M
    J Cardiovasc Pharmacol; 2001 Oct; 38 Suppl 1():S81-5. PubMed ID: 11811366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of enhanced bioavailability and diuretic effect of azosemide by ascorbic acid in rats.
    Choi KY; Kim YC; Lee MG
    Life Sci; 2006 Feb; 78(10):1057-62. PubMed ID: 16153662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determination and interpretation of the diuretic equivalence of azosemid and furosemide].
    Gerová Z; Nándoryová M; Dzúrik R
    Vnitr Lek; 1982 Mar; 28(3):266-73. PubMed ID: 6896778
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.